Global Ventricular Assist Devices Market Detail Analysis focusing on Key Players Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic, Terumo Corporation
U.S. ventricular assist devices market is estimated to grow at robust CAGR of 9.8% over the forecast timeframe. As per the American College of Cardiology, around 800,000 die in the U.S. because of cardiovascular diseases. Growing prevalence of CVD diseases, rise in sedentary lifestyle among the people, growing heart failure rate among the Americans and recent technological advancements will be a major market driving factor in the country.
Request a sample of this report at: https://www.marketstudyreport.com/request-a-sample/1357103/
Ventricular Assist Devices Market will exceed USD 2.0 billion by 2024; as per a new research report. Japan dominated the Asia Pacific ventricular assist devices market and was valued around USD 22.0 million in the year 2017. According to recent study, the prevalence of CVD and heart failure in the people have increased at a significant rate in the past few years. The growing geriatric population prone to lifestyle diseases such as cardiovascular diseases will be responsible for the growth of ventricular assist devices in the region.
Percutaneous ventricular assist device market held significant amount of market share and was valued around USD 99.9 million in the year 2017. Increase in number of right ventricle failure rates has led to growing use of percutaneous VAD. Several advantages provided by percutaneous VAD such as safety, easy to implant and high reliability for survival will increase the demand and adoption rate of the device, augmenting the market growth.
Bridge-to-transplant (BTT) therapy market is estimated to grow substantially at a CAGR of 10.4% during the forecast period. As per the recent research reports, BTT-VAD therapy is associated with increase in patient?s survival rate and cost-effectiveness. Hence, decreased treatment and device cost will increase the adoption rate of device in the low and middle income population, fueling the business growth in the upcoming years.
The sales of ventricular assist devices in the people aged between 40-59 years of age in the year 2017 was around USD 420.2 million. The rise in prevalence of heart failure among the people of this age group will be the main reason behind the increasing sale of ventricular assist devices during the projection period.
Request a discount on standard prices of this report at: https://www.marketstudyreport.com/check-for-discount/1357103/
Recent rise in awareness about the emerging treatment and use of ventricular assist devices for heart failure in the developing region of Latin America will drive the industry growth in the near future. Growing mortality rates and hospitalization in the Latin America region due to high prevalence of heart failure rates will enhance the growth of ventricular assist devices market growth in the forthcoming years.
Lack of heart donors across the globe will be one of the major market boosting factors. According to a recent research survey, it was found that heart donation shortage is likely to increase in the near future with heart failure rate prevalence increasing multifold and heart donors growing steadily. The high prevalence of heart failure across the globe and shortage of heart donors will lead to increase in demand and adoption rate of ventricular assist devices, fueling the market growth.
Some of the leading players in the ventricular assist devices market include Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic, Terumo Corporation and others. These companies focus on strategic decisions such as partnerships and collaborations to increase the research and development investment and expand their product portfolio. Merger and acquisitions have resulted in the company?s geographical expansion and boosted their efficiency to sustain in the market by providing better products.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Ventricular assist devices Industry Insights
Chapter 4. Ventricular assist devices Market, By Product
Chapter 5. Ventricular assist devices Market, By Application
Chapter 6. Ventricular assist devices Market, By Age
Chapter 7. Ventricular assist devices Market, By Region
Chapter 8. Company Profiles
For More Details On this Report: https://www.marketstudyreport.com/reports/ventricular-assist-devices-market
Global Ventricular Assist Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Ventricular assist device, which is also known as VAD, is a mechanically assisted pump which is being used to support heart function and flow of blood in people who have weakened hearts. Ventricular assist device works by taking blood from a lower chamber of the heart and helps pump it to the body & organs similar to a healthy heart. A VAD supports patient?s heart through or after surgery until the heart recovers, while patient is waiting for a heart transplant or if patient is not eligible for a heart transplant. A VAD can also be a long-term solution for patients with cardiac disorders.
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ventricular Assist Devices Market Detail Analysis focusing on Key Players Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic, Terumo Corporation here
News-ID: 1602330 • Views: 445
More Releases from marketstudyreport.com
What's driving the Solar District Heating Market Trends? Savosolar. Goteberg Ene …
Market Study Report, LLC’s, latest study on ‘Solar District Heating market’ features a holistic view of the market size, market share, profit estimates, SWOT analysis and the regional landscape of the business. The report precisely expounds key challenges and future growth prospects of the market, while highlighting the current competitive scene and analyzes the expansion strategies adopted by leading market players. Solar District Heating Market share is set to surpass USD
What's driving the Structural Steel Market trends? Gerdau S.A, ArcelorMittal, Ta …
A detailed study on ‘Structural Steel market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
What's driving the Blockchain Technology Market Trends? Deloitte, BTL Group Ltd. …
A detailed study on ‘Blockchain Technology Market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
What's driving the Antidiabetics Market trends? Sanofi, Bayer Corporation, Novar …
A detailed study on ‘Antidiabetics market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in the
More Releases for Ventricular
Latest Evolution of Ventricular Drainage Sets Market Analysis 2026
Ventricular Drainage Sets Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Ventricular Drainage Sets market research report is a professional and in-depth study on the current state of Ventricular Drainage Sets Industry. The Ventricular Drainage Sets Market research report covers the present scenario and
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction Overview Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction. Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018 Top Companies mentioned Bayer AG Innopharmax Inc Mesoblast Ltd Novartis AG Quantum Genomics SA TiGenix NV Left Ventricular Dysfunction Industry Major Outlook Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -
Ventricular Tachycardia Market Forecast Report Offers Actionable Insights 2017 - …
Ventricular tachycardia is a condition, wherein the pulse rate is more than 100 beats per minute with minimum three continuous irregular heartbeats. This condition occurs in bottom chambers of the heart and develops as an early or late complication of heart attack. Patients suffering from cardiomyopathy, myocarditis, or valvular heart disease are at a higher risk of developing ventricular tachycardia. Major reasons for ventricular tachycardia are changes in pH values,
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease. Report Highlights Publisher's Pharmaceutical and Healthcare
Ventricular Tachycardia Treatment Market And Segment Forecasts To 2017 – 2025
Ventricular tachycardia is a life threatening heart condition in which arrhythmic heart beats occur in the ventricles. The two lower chambers of the heart are known as ventricles. They are responsible for supplying the blood received from atria to different parts of the body. When a person suffers from ventricular tachycardia, a high pulse with more than 100 beats per minute is registered with minimum 3 irregular heartbeats experienced in
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major